NCT05833139View on ClinicalTrials.gov

A Study in Healthy Men to Test How Itraconazole Influences the Amount of Zongertinib (BI 1810631) in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 14, 2023

Primary Completion Date

June 12, 2023

Study Completion Date

June 12, 2023

Conditions
Healthy
Interventions
DRUG

Zongertinib

Zongertinib

DRUG

Itraconazole

Itraconazole

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY